Browsing Tag
NASDAQ
352 posts
Brand Engagement Network exits $50m equity line to reset dilution profile and capital discipline (NASDAQ: BNAI)
Brand Engagement Network has terminated a $50M equity line to cut dilution risk. Find out how this move could reshape investor sentiment and AI execution.
VHUB listing: VenHub Global Inc’s Nasdaq entry bets on autonomous retail format and smart infrastructure
Discover how VenHub Global Inc’s Nasdaq direct listing under VHUB advances autonomous retail infrastructure and what this means for investors and industry.
Can Galmed Pharmaceuticals avoid delisting? Nasdaq compliance clock is ticking
Nasdaq has notified Galmed Pharmaceuticals of a share price deficiency. Find out what this means for investors and the company's future strategy.
What’s going on at Olema Oncology? CFO + COO Hans Bishop exits suddenly
Olema Oncology CFO and COO Hans Bishop has stepped down ahead of OP-1250 trial milestones. Find out what this means for investors and pipeline strategy.
How Austria’s Wolfsberg renewal strengthens Critical Metals Corp’s timing leverage in a tightening lithium market (NASDAQ: CRML)
Austria extends Wolfsberg’s license, giving Critical Metals Corp time to align lithium development with market recovery. Find out why this timing matters now.
VSE Corporation’s Precision Aviation Group acquisition reshapes competitive dynamics in the global aviation aftermarket (NASDAQ: VSEC)
Find out how VSE Corporation’s $2 billion Precision Aviation Group acquisition could reshape aviation aftermarket margins and competitive dynamics.
Why addiction treatment companies like Indivior are re-anchoring corporate control in the U.S.
Find out why Indivior’s U.S. redomiciliation signals a broader strategic shift across addiction treatment and regulated healthcare companies.
Why the U.S. Air Force is betting on Palladyne AI to unify satellites, drones, and unmanned systems at scale
Discover why Palladyne AI’s Air Force contract signals a strategic shift toward cross-domain autonomous warfare and what it means for defense AI.
When strategic intent meets execution risk: inside SwiftStart’s proposed stake in TIRX
SwiftStart’s $80M investment intent puts TIRX under the microscope. Find out what the proposed deal really means for valuation, risk, and execution.
NVIDIA (NASDAQ: NVDA) stock edges up to $188.52 as AI bulls test conviction ahead of earnings
NVIDIA stock closed up 1.10% at $188.52 with after-hours gains. Find out what this price action signals for AI momentum and earnings sentiment.